Dianthus Therapeutics, Inc. /DE/ Quarterly Nonoperating Income (Expense) in USD from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2022 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.73M, a 374% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $15.8M.
  • Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2023 was $4.62M, a 276% increase from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2022 was $1.23M.
  • Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2021 was -$23K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $15.8M $4.73M +$3.73M +374% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $12.1M $4.6M +$3.96M +623% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.12M $4.1M +$3.5M +590% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.62M $2.39M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $996K +$526K +112% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $636K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $594K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $470K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.